PanGen Biotech (Korea) Market Value

222110 Stock  KRW 6,110  60.00  0.97%   
PanGen Biotech's market value is the price at which a share of PanGen Biotech trades on a public exchange. It measures the collective expectations of PanGen Biotech investors about its performance. PanGen Biotech is trading at 6110.00 as of the 24th of November 2024, a 0.97 percent decrease since the beginning of the trading day. The stock's open price was 6170.0.
With this module, you can estimate the performance of a buy and hold strategy of PanGen Biotech and determine expected loss or profit from investing in PanGen Biotech over a given investment horizon. Check out PanGen Biotech Correlation, PanGen Biotech Volatility and PanGen Biotech Alpha and Beta module to complement your research on PanGen Biotech.
Symbol

Please note, there is a significant difference between PanGen Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if PanGen Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PanGen Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PanGen Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PanGen Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PanGen Biotech.
0.00
12/05/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/24/2024
0.00
If you would invest  0.00  in PanGen Biotech on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding PanGen Biotech or generate 0.0% return on investment in PanGen Biotech over 720 days. PanGen Biotech is related to or competes with Iljin Display, SM Entertainment, Ssangyong Information, MEDIANA CoLtd, Korea Computer, Daewon Media, and Tamul Multimedia. PanGen Biotech Inc. operates as a specialized biologics company in South Korea More

PanGen Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PanGen Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PanGen Biotech upside and downside potential and time the market with a certain degree of confidence.

PanGen Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for PanGen Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PanGen Biotech's standard deviation. In reality, there are many statistical measures that can use PanGen Biotech historical prices to predict the future PanGen Biotech's volatility.
Hype
Prediction
LowEstimatedHigh
6,1046,1106,116
Details
Intrinsic
Valuation
LowRealHigh
5,8165,8216,721
Details
Naive
Forecast
LowNextHigh
5,8225,8285,834
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6,0736,1306,187
Details

PanGen Biotech Backtested Returns

PanGen Biotech appears to be very steady, given 3 months investment horizon. PanGen Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing PanGen Biotech's technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please evaluate PanGen Biotech's Risk Adjusted Performance of 0.098, semi deviation of 2.71, and Coefficient Of Variation of 857.9 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PanGen Biotech holds a performance score of 10. The company holds a Beta of -0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning PanGen Biotech are expected to decrease at a much lower rate. During the bear market, PanGen Biotech is likely to outperform the market. Please check PanGen Biotech's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether PanGen Biotech's historical price patterns will revert.

Auto-correlation

    
  0.46  

Average predictability

PanGen Biotech has average predictability. Overlapping area represents the amount of predictability between PanGen Biotech time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PanGen Biotech price movement. The serial correlation of 0.46 indicates that about 46.0% of current PanGen Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient0.46
Spearman Rank Test0.45
Residual Average0.0
Price Variance785.3 K

PanGen Biotech lagged returns against current returns

Autocorrelation, which is PanGen Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PanGen Biotech's stock expected returns. We can calculate the autocorrelation of PanGen Biotech returns to help us make a trade decision. For example, suppose you find that PanGen Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

PanGen Biotech regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PanGen Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PanGen Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PanGen Biotech stock over time.
   Current vs Lagged Prices   
       Timeline  

PanGen Biotech Lagged Returns

When evaluating PanGen Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PanGen Biotech stock have on its future price. PanGen Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PanGen Biotech autocorrelation shows the relationship between PanGen Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in PanGen Biotech.
   Regressed Prices   
       Timeline  

Pair Trading with PanGen Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PanGen Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against PanGen Stock

  0.82235980 MedPactoPairCorr
  0.73302440 SK BiosciencePairCorr
  0.73086890 ISU AbxisPairCorr
  0.57144510 Green Cross LabPairCorr
  0.5244460 OLIPASS SplitPairCorr
The ability to find closely correlated positions to PanGen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PanGen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PanGen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PanGen Biotech to buy it.
The correlation of PanGen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PanGen Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PanGen Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PanGen Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in PanGen Stock

PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.